» Authors » Georgios Evangelou

Georgios Evangelou

Explore the profile of Georgios Evangelou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 32
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Koumaki D, Koumaki V, Gregoriou S, Evangelou G, Rovithi E, Petrou D, et al.
Int J Dermatol . 2025 Mar; PMID: 40022487
No abstract available.
2.
Koumaki D, Maraki S, Evangelou G, Koumaki V, Gregoriou S, Kouloumvakou S, et al.
J Clin Med . 2025 Feb; 14(4). PMID: 40004615
Methicillin-resistant (MRSA) poses significant treatment challenges, particularly in community settings. Limited data are available on -associated infected dermatoses (ID) in outpatient dermatology clinics. This study examines the clinical characteristics, microbiological...
3.
Koumaki D, Evangelou G, Gregoriou S, Kouloumvakou S, Manios A, Katoulis A, et al.
Cancers (Basel) . 2025 Jan; 16(24. PMID: 39766125
Backgorund: This study aimed to explore the relationship between different types of skin cancer and factors such as sun exposure and photoprotection measures in a Greek cohort on the island...
4.
Koumaki D, Gregoriou S, Evangelou G, Rovithi E, Koumaki V, Petrou D, et al.
Int J Dermatol . 2024 Dec; 64(3):571-574. PMID: 39654389
No abstract available.
5.
Koumaki D, Evangelou G, Marazaki F, Petrou D, Gorgomiti M, Gregoriou S, et al.
J Eur Acad Dermatol Venereol . 2024 Sep; PMID: 39291909
No abstract available.
6.
Koumaki D, Maraki S, Evangelou G, Rovithi E, Petrou D, Apokidou E, et al.
J Clin Med . 2024 Aug; 13(15). PMID: 39124594
is a coagulase-negative staphylococcus (CoNS) commonly found on human skin. Unlike other CoNS, has a notable potential to cause severe infections comparable to . This study aimed to characterize the...
7.
Koumaki D, Evangelou G, Maraki S, Rovithi E, Petrou D, Apokidou E, et al.
J Clin Med . 2024 Jul; 13(14). PMID: 39064287
: Antibiotic (AB) therapy is the first step in managing hidradenitis suppurativa (HS). Knowledge of the local patterns of antimicrobial resistance is paramount for the appropriate selection of antimicrobials. This...
8.
Evangelou G, Vamvakaris I, Konstantopoulou I, Syrigos K
Oncology (Williston Park) . 2024 Jul; 38(7):264-268. PMID: 39024198
Neoadjuvant and adjuvant treatment in lung neuroendocrine tumors (NETs) is a field that has not been explored in-depth, with little information on the impact on disease-free survival. This case study...
9.
Koumaki D, Evangelou G, Katoulis A, Apalla Z, Lallas A, Papadakis M, et al.
BMC Cancer . 2024 Jul; 24(1):785. PMID: 38951767
Background: Merkel cell carcinoma (MCC) is a rare, aggressive, cutaneous tumour with high mortality and frequently delayed diagnosis. Clinically, it often manifests as a rapidly growing erythematous to purple nodule...
10.
Evangelou G, Trontzas I, Gkiozos I, Vamvakaris I, Paraskeva C, Grammoustianou M, et al.
Biomedicines . 2024 Jun; 12(6). PMID: 38927367
Background: Large cell neuroendocrine carcinoma (LCNEC) presents significant treatment challenges due to its rarity and limited therapeutic options. The LANCE study was designed to explore the survival benefits of incorporating...